MILLER ECONOMICS
Payer Matters in Development | Dossiers | Market

In Development

Odomzo® (Sun Pharma) - BCC
Lorbrena® (Pfizer) - NSCLC
Vizimpro® (Pfizer) - NSCLC
Kisqali® (Novartis) - aBC
Piqray® (Novartis) - aBC
Darzalex® (Janssen) - MM
Resiquimod® (Galderma) - CTCL
Nerlynx® (Puma) - aBC
Olumiant® (Lilly) - RA
Etrasimod® (Arena) - UC
Sunosi® (Jazz) - EDS
Bempedoic Acid (D-S) - CV
Abicipar® (Allergan) - wAMD

In Dossiers

Erleada® (Janssen) - nmCRPC
Venclexta® (AbbVie) - CLL
Xospata® (Astellas) - AML
Bavencio® (Pfizer/Merck) - aRCC
Lynparza® (AZ) - aOC
Imfinzi® (AZ) - NSCLC
Tagrisso® (AZ) - NSCLC
Polivy® (Roche) - DLBCL
Jorveza® (Dr Falk) - GI
Rinvoq® (AbbVie) - RA
Veltassa® (Vifor) - hyperkalemia
Alofisel® (Takeda) - CD
Crysvita® (KKI) - XLH

In Market

Zolgensma® (AveXis) - SMA

Dupixent® (Sanofi) - AD, +

Penthrox® (Galen) - trauma pain

Airsonett® Air (Airsonett) - allergic asthma, eczema [device]

Innovative contracting (Vertex)

0